<p>, /PRNewswire/ -- <strong>Edelson Lechtzin LLP</strong> 正在調查涉及 Agilon Health, Inc.（&#34;Agilon&#34; 或 &#34;公司&#34;）（NYSE: AGL）的潛在聯邦證券法違規行為，原因是有指控稱其向投資公眾提供了可能誤導的商業信息。</p>
<p><strong>如果您有可能協助 Agilon 調查的信息，或者您是遭受損失的 Agilon 投資者並希望瞭解更多信息，您可以在此提供您的信息</strong> <strong>HERE</strong> <strong>。</strong></p>
<p><strong>您也可以通過撥打 844-563-5550 或發送電子郵件至</strong> <strong>[email protected]</strong> <strong>聯繫 Edelson Lechtzin LLP 的律師 Eric Lechtzin。</strong></p>
<p><strong>公司簡介：</strong></p>
<p>Agilon Health 與初級保健醫生合作，提供協調的、基於價值的老年護理。</p>
<p><strong>指控的不當行為</strong> <em>:</em></p>
<p>2025 年 8 月 4 日，Agilon Health 公佈了 2025 年第二季度的業績，執行主席承認行業挑戰比預期更加嚴峻。該公司還暫停了全年的財務指引。消息公佈後，Agilon Health 的股票在 2025 年 8 月 5 日暴跌了 51.5%。</p>
<p><strong>關於 EDELSON LECHTZIN LLP：</strong> Edelson Lechtzin LLP 是一家在賓夕法尼亞州和加利福尼亞州設有辦事處的全國性集體訴訟律師事務所。除了涉及證券和投資欺詐的案件外，我們的律師還專注於指控違反聯邦反壟斷法、ERISA 員工福利計劃、工資盜竊和未支付加班費、消費者欺詐以及危險和缺陷藥物和醫療設備的集體和聯合訴訟。</p>
<p>如需更多信息，請聯繫：</p>
<p>Marc H. Edelson, Esq.</p>
<p>Eric Lechtzin, Esq.</p>
<p>EDELSON LECHTZIN LLP</p>
<p>411 S. State Street, Suite N-300</p>
<p>Newtown, PA 18940</p>
<p>電話：844-696-7492 或 215-867-2399 ext. 1</p>
<p>電子郵件：[email protected]</p>
<p>電子郵件：[email protected]</p>
<p>網站：www.edelson-law.com</p>
<p>本新聞稿在某些司法管轄區可能被視為律師廣告。本案尚未認證任何集體，因此除非您聘請律師，否則您不受律師的代表。您可以選擇您自己的律師。您也可以保持缺席集體成員身份，目前不採取任何行動。您分享任何潛在未來賠償的能力不依賴於擔任首席原告。</p>
<p>來源：Edelson Lechtzin LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTEwJk5ld3NJdGVtSWQ9UEgyMDUzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTAxNDQ2UFJfTkVXU19VU1BSX19fX19QSDIwNTM4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTEwJk5ld3NJdGVtSWQ9UEgyMDUzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTAxNDQ2UFJfTkVXU19VU1BSX19fX19QSDIwNTM4"/></p>

<p>Edelson Lechtzin LLP 正在調查 Agilon Health, Inc.（紐約證券交易所代碼：AGL）是否存在違反聯邦證券法的潛在行為，原因是有關於誤導性商業信息的指控。在 Agilon 宣佈面臨嚴重行業挑戰並暫停財務指引後，該公司股票在 2025 年 8 月 5 日下跌了 51.5%。遭受重大損失的投資者被鼓勵聯繫該公司尋求幫助</p>

<p>, /PRNewswire/ -- <strong>Edelson Lechtzin LLP</strong> is investigating potential violations of the federal securities laws involving Agilon Health, Inc. (&#34;Agilon&#34; or &#34;the Company&#34;) (NYSE: AGL), resulting from allegations of providing potentially misleading business information to the investing public.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- <strong>Edelson Lechtzin LLP</strong> 正在調查涉及 Agilon Health, Inc.（&#34;Agilon&#34; 或 &#34;公司&#34;）（NYSE: AGL）的潛在聯邦證券法違規行為，原因是有指控稱其向投資公眾提供了可能誤導的商業信息。</p>
</div><p><strong>If you have information that could assist in the Agilon investigation or if you are an Agilon investor who suffered a loss and would like to learn more, you can provide your information</strong> <strong>HERE</strong> <strong>.</strong></p>
<div class="lb-trans"><p><strong>如果您有可能協助 Agilon 調查的信息，或者您是遭受損失的 Agilon 投資者並希望瞭解更多信息，您可以在此提供您的信息</strong> <strong>HERE</strong> <strong>。</strong></p>
</div><p><strong>You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at</strong> <strong>[email protected]</strong> <strong>.</strong></p>
<div class="lb-trans"><p><strong>您也可以通過撥打 844-563-5550 或發送電子郵件至</strong> <strong>[email protected]</strong> <strong>聯繫 Edelson Lechtzin LLP 的律師 Eric Lechtzin。</strong></p>
</div><p><strong>THE COMPANY:</strong></p>
<div class="lb-trans"><p><strong>公司簡介：</strong></p>
</div><p>Agilon Health partners with primary care doctors to deliver coordinated, value-based senior care.</p>
<div class="lb-trans"><p>Agilon Health 與初級保健醫生合作，提供協調的、基於價值的老年護理。</p>
</div><p><strong>THE ALLEGED WRONGDOING</strong> <em>:</em></p>
<div class="lb-trans"><p><strong>指控的不當行為</strong> <em>:</em></p>
</div><p>On August 4, 2025, Agilon Health announced its second-quarter 2025 results, with the Executive Chair acknowledging that industry challenges had become more severe than expected. The company also suspended its full-year financial guidance. Following the news, Agilon Health's stock plummeted 51.5% on August 5, 2025.</p>
<div class="lb-trans"><p>2025 年 8 月 4 日，Agilon Health 公佈了 2025 年第二季度的業績，執行主席承認行業挑戰比預期更加嚴峻。該公司還暫停了全年的財務指引。消息公佈後，Agilon Health 的股票在 2025 年 8 月 5 日暴跌了 51.5%。</p>
</div><p><strong>ABOUT EDELSON LECHTZIN LLP:</strong> Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation alleging violations of the federal antitrust laws, ERISA employee benefit plans, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.</p>
<div class="lb-trans"><p><strong>關於 EDELSON LECHTZIN LLP：</strong> Edelson Lechtzin LLP 是一家在賓夕法尼亞州和加利福尼亞州設有辦事處的全國性集體訴訟律師事務所。除了涉及證券和投資欺詐的案件外，我們的律師還專注於指控違反聯邦反壟斷法、ERISA 員工福利計劃、工資盜竊和未支付加班費、消費者欺詐以及危險和缺陷藥物和醫療設備的集體和聯合訴訟。</p>
</div><p>For more information, please contact:</p>
<div class="lb-trans"><p>如需更多信息，請聯繫：</p>
</div><p>Marc H. Edelson, Esq.</p>
<div class="lb-trans"><p>Marc H. Edelson, Esq.</p>
</div><p>Eric Lechtzin, Esq.</p>
<div class="lb-trans"><p>Eric Lechtzin, Esq.</p>
</div><p>EDELSON LECHTZIN LLP</p>
<div class="lb-trans"><p>EDELSON LECHTZIN LLP</p>
</div><p>411 S. State Street, Suite N-300</p>
<div class="lb-trans"><p>411 S. State Street, Suite N-300</p>
</div><p>Newtown, PA 18940</p>
<div class="lb-trans"><p>Newtown, PA 18940</p>
</div><p>Phone: 844-696-7492 or 215-867-2399 ext. 1</p>
<div class="lb-trans"><p>電話：844-696-7492 或 215-867-2399 ext. 1</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>電子郵件：[email protected]</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>電子郵件：[email protected]</p>
</div><p>Web: www.edelson-law.com</p>
<div class="lb-trans"><p>網站：www.edelson-law.com</p>
</div><p>This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p>
<div class="lb-trans"><p>本新聞稿在某些司法管轄區可能被視為律師廣告。本案尚未認證任何集體，因此除非您聘請律師，否則您不受律師的代表。您可以選擇您自己的律師。您也可以保持缺席集體成員身份，目前不採取任何行動。您分享任何潛在未來賠償的能力不依賴於擔任首席原告。</p>
</div><p>SOURCE Edelson Lechtzin LLP</p>
<div class="lb-trans"><p>來源：Edelson Lechtzin LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTEwJk5ld3NJdGVtSWQ9UEgyMDUzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTAxNDQ2UFJfTkVXU19VU1BSX19fX19QSDIwNTM4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=PH20538&amp;Transmission_Id=202511101446PR_NEWS_USPR_____PH20538&amp;DateId=20251110"/></p>

14:46 ET
			
			
				INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Agilon Health, Inc. (NYSE: AGL) and Encourages Investors with Substantial Losses to Contact the Firm

調查警報：Edelson Lechtzin LLP 宣佈對 agilon health, Inc.（NYSE: AGL）的調查，並鼓勵遭受重大損失的投資者與該律所聯繫